Offering unmatched regenerative power, Exometics™ G delivers superior skin renewal, elasticity, and anti-aging benefits while overcoming the ethical, regulatory, and consumer concerns of first-generation exosomes.
Unlike currently available exosome solutions, which often provide unquantified and inconsistent vesicle concentrations, Exometics™ G is precisely dosed, with over 10 billion vesicles/mL — allowing brands to claim above 10 millions of exosomes per drop in a formulated cream or serum, ensuring superior biological activity and efficacy in final formulations.
With patented bioengineering process, a controlled 150 nm particle size for optimal cell delivery, and unrivaled consistency, Exometics™ G is setting a new gold standard for next-generation skin care
A next-generation, ethical alternative to animal-derived exosomes with a patented process
Exosomes are at the forefront of regenerative science, but most commercial offerings are derived from animal or plant sources, presenting challenges in sustainability, reproducibility, very low yield and regulatory approvals. Exometics™ G provides a breakthrough solution.
Harnessing advanced biomimetic bioengineering, ALGAKTIV has developed a lab-grown alternative that mirrors the structure, composition, and functionality of human exosomes—but without relying on animal-derived materials
Key advantages of Exometics™ G over traditional exosomes:
- Controlled Particle Size – 150 nm diameter, ensuring precise and effective cellular uptake for optimal skin penetration
- 100% Vegan & Cruelty-Free – No animal or human-derived materials, aligning with clean beauty and ethical standards
- Unmatched Vesicle Concentration – above 10 millions of vesicle per drop of formulated finished product, delivering proven skin renewal efficacy
- Sustainable & Scalable – Lab-grown with unlimited production capacity, eliminating reliance on natural harvesting
- Patented Technology – A proprietary bioengineering process ensuring batch-to-batch consistency and maximum potency
"We recognized that traditional exosome solutions had major limitations—from ethical
concerns to batch variability and inconsistent efficacy," says Jordi Ayats, Product Director at ALGAKTIV®. "With Exometics™ G, we have developed a patented technology that provides a standardized, high-potency, and clinically validated alternative, allowing brands to claim exosomal performance in their final formulations."
Clinically proven performance: you look 2 years younger in 14 days!
Exometics™ G has undergone rigorous in vitro and clinical testing, demonstrating significant and statistically validated improvements in skin renewal, elasticity, firmness, and brightness.
Key clinical results of Exometics™ G:
- 30.6% faster wound healing in just 8 hours (in vitro human fibroblast study)
- Visible firming & lifting effects, confirmed via Cutometer R0 parameter measurement 2.2 years of biological wrinkle reversal in just 14 days (Primos-CR SF imaging study)
- +300% improvement in skin smoothness vs placebo, with a reduction in surface roughness over 56 days
- 25% reduction in hyperpigmentation after 56 days, visibly fading dark spots and discoloration
- +15% increase in skin radiance in 28 days, for a brighter, healthier glow
These results make Exometics™ G the most advanced skin care biomimetic exosome technology available today, offering brands the ability to formulate high-performance,
results-driven products.
"Consumers are demanding more than just ‘clean beauty’—they want ethical skin care that actually works," explains Alexandre Lapeyre, Marketing Director at ALGAKTIV®. Exometics™ G isn’t just another active—it’s a technological leap forward, providing scientifically validated, scalable, and lab-engineered biomimetic exosomes that meet the performance standards of next-generation regenerative skin care."
A new era of regenerative skin care
By bridging cutting-edge biotechnology with clean beauty, ALGAKTIV is redefining how exosome technology can be applied in high-performance skin care.
With Exometics™ G, brands now have access to a patented, ethically sourced, and scientifically superior exosome solution—allowing them to create groundbreaking anti-aging, repair, and brightening formulations with verified claims and next-level efficacy
"We believe Exometics™ G is the future of regenerative skin care," concludes Alexandre Lapeyre. "It’s not just about replacing traditional exosomes—it’s about delivering a better, purer, and more effective solution that meets the demands of both brands and consumers alike."
